These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2161885

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.
    Carel JC, Myones BL, Frazier B, Holers VM.
    J Biol Chem; 1990 Jul 25; 265(21):12293-9. PubMed ID: 1695627
    [Abstract] [Full Text] [Related]

  • 3. Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2).
    Moore MD, DiScipio RG, Cooper NR, Nemerow GR.
    J Biol Chem; 1989 Dec 05; 264(34):20576-82. PubMed ID: 2555366
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus/complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti-CR2 antibodies.
    Barel M, Fiandino A, Lyamani F, Frade R.
    Proc Natl Acad Sci U S A; 1989 Dec 05; 86(24):10054-8. PubMed ID: 2557614
    [Abstract] [Full Text] [Related]

  • 5. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.
    Nemerow GR, Mold C, Schwend VK, Tollefson V, Cooper NR.
    J Virol; 1987 May 05; 61(5):1416-20. PubMed ID: 3033269
    [Abstract] [Full Text] [Related]

  • 6. Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2.
    Martin DR, Yuryev A, Kalli KR, Fearon DT, Ahearn JM.
    J Exp Med; 1991 Dec 01; 174(6):1299-311. PubMed ID: 1660522
    [Abstract] [Full Text] [Related]

  • 7. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.
    Delcayre AX, Salas F, Mathur S, Kovats K, Lotz M, Lernhardt W.
    EMBO J; 1991 Apr 01; 10(4):919-26. PubMed ID: 1849076
    [Abstract] [Full Text] [Related]

  • 8. Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.
    Lowell CA, Klickstein LB, Carter RH, Mitchell JA, Fearon DT, Ahearn JM.
    J Exp Med; 1989 Dec 01; 170(6):1931-46. PubMed ID: 2479703
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats.
    Moore MD, Cannon MJ, Sewall A, Finlayson M, Okimoto M, Nemerow GR.
    J Virol; 1991 Jul 01; 65(7):3559-65. PubMed ID: 1645784
    [Abstract] [Full Text] [Related]

  • 10. Intracellular interaction of EBV/C3d receptor (CR2) with p68, a calcium-binding protein present in normal but not in transformed B lymphocytes.
    Barel M, Gauffre A, Lyamani F, Fiandino A, Hermann J, Frade R.
    J Immunol; 1991 Aug 15; 147(4):1286-91. PubMed ID: 1831222
    [Abstract] [Full Text] [Related]

  • 11. Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21).
    Young KA, Chen XS, Holers VM, Hannan JP.
    J Biol Chem; 2007 Dec 14; 282(50):36614-25. PubMed ID: 17925391
    [Abstract] [Full Text] [Related]

  • 12. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins.
    Weis JJ, Toothaker LE, Smith JA, Weis JH, Fearon DT.
    J Exp Med; 1988 Mar 01; 167(3):1047-66. PubMed ID: 2832506
    [Abstract] [Full Text] [Related]

  • 13. Stable expression and function of EBV/C3d receptor following genomic transfection into murine fibroblast L cells.
    Cantaloube JF, Piechaczyk M, Calender A, Lenoir G, Minty A, Carrière D, Fischer E, Poncelet P.
    Eur J Immunol; 1990 Feb 01; 20(2):409-16. PubMed ID: 1690137
    [Abstract] [Full Text] [Related]

  • 14. Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interaction.
    Molina H, Brenner C, Jacobi S, Gorka J, Carel JC, Kinoshita T, Holers VM.
    J Biol Chem; 1991 Jul 05; 266(19):12173-9. PubMed ID: 1712014
    [Abstract] [Full Text] [Related]

  • 15. Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.
    Tuveson DA, Ahearn JM, Matsumoto AK, Fearon DT.
    J Exp Med; 1991 May 01; 173(5):1083-9. PubMed ID: 1708808
    [Abstract] [Full Text] [Related]

  • 16. Purification of the Epstein-Barr virus/C3d complement receptor of human B lymphocytes: antigenic and functional properties of the purified protein.
    Nemerow GR, Siaw MF, Cooper NR.
    J Virol; 1986 May 01; 58(2):709-12. PubMed ID: 2422399
    [Abstract] [Full Text] [Related]

  • 17. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR, McNaughton ME, Cooper NR.
    J Immunol; 1985 Nov 01; 135(5):3068-73. PubMed ID: 2995485
    [Abstract] [Full Text] [Related]

  • 18. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2.
    Hedrick JA, Watry D, Speiser C, O'Donnell P, Lambris JD, Tsoukas CD.
    Eur J Immunol; 1992 May 01; 22(5):1123-31. PubMed ID: 1315687
    [Abstract] [Full Text] [Related]

  • 19. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.
    Weis JJ, Fearon DT, Klickstein LB, Wong WW, Richards SA, de Bruyn Kops A, Smith JA, Weis JH.
    Proc Natl Acad Sci U S A; 1986 Aug 01; 83(15):5639-43. PubMed ID: 3016712
    [Abstract] [Full Text] [Related]

  • 20. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM, Fowler E, Lambris JD, Feighny RJ, Simmons JG, Ross GD.
    J Immunol; 1983 Mar 01; 130(3):1309-12. PubMed ID: 6218205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.